Proanthocyanidins from Ginkgo biloba extract EGb 761® exert antioxidative activity in vitro and antiamnesic activity in vivo.

Front Pharmacol · 2025 · PMC12597941 · PMID 41221046

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

However, only the finished product with a high PAC content showed a statistically significant effect (63% reversal of the effect of scopolamine, p < 0.001), whereas the improvement induced by the low-PAC product did not reach statistical significance (34% reversal, p > 0.05) ( Figure 8 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Proanthocyanidins from &lt;i&gt;Ginkgo biloba&lt;/i&gt; extract EGb 761&lt;sup&gt;®&lt;/sup&gt; exert antioxidative activity &lt;i&gt;in vitro&lt;/i&gt; and antiamnesic activity &lt;i&gt;in vivo&lt;/i&gt;.

The sentences

Proanthocyanidins from <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup> exert antioxidative activity <i>in vitro</i> and antiamnesic activity <i>in vivo</i>.